BLISS-LN (2020) — Trial Summary

BLISS-LN (2020): The BLISS-LN trial evaluated the efficacy and safety of belimumab, a B-lymphocyte stimulator inhibitor, added to standard therapy in patients with active lupus nephritis.

References

NephroResource

Taking longer than expected

If you're on a slow connection or this keeps happening, tap below to reload.